Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.6400
+0.0310 (5.09%)
At close: Aug 25, 2026, 4:00 PM EDT
0.6433
+0.0033 (0.52%)
After-hours: Aug 25, 2026, 7:58 PM EDT
Outlook Therapeutics Stock Forecast
OTLK's stock price has decreased by -76.12% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 analysts polled by S&P Global, Outlook Therapeutics stock has a consensus rating of "Buy" and an average price target of $4.90. The average 1-year stock price forecast is 665.63% higher than the current stock price, while the lowest is $1.60 (+150.00%) and the highest is $10 (+1,462.50%).
Price Target: $4.90 (+665.63%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Outlook Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Reiterates $4 | Buy | Reiterates | $4 | +525.00% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $1.6 | Hold | Reiterates | $1.6 | +150.00% | Jul 27, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $6 → $10 | Buy | Maintains | $6 → $10 | +1,462.50% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
824.00K
from 1.41M
Decreased by -41.71%
Revenue Next Year
41.57M
from 824.00K
Increased by 4,944.99%
EPS This Year
-0.42
from -1.89
EPS Next Year
-0.14
from -0.42
EPS and Forward PE are based on non-GAAP adjusted numbers.